IPG Investment Advisors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,385
Closed -$577K 166
2022
Q1
$577K Buy
3,385
+646
+24% +$109K 0.11% 89
2021
Q4
$707K Buy
2,739
+1,965
+254% +$538K 0.13% 89
2021
Q3
$211K Buy
+774
New +$246K 0.07% 112

Other funds holding BNTX

IPG Investment Advisors's BNTX Position: Q2 2022 in Review

IPG Investment Advisors sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 3,385 shares — an estimated $577K sold.

IPG Investment Advisors first reported a position in BNTX in Q3 2021 and held it in 3 quarters. The position peaked at $707K in Q4 2021. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

  • IPG Investment Advisors reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
  • IPG Investment Advisors sold 3,385 BioNTech shares in Q2 2022, an estimated $577K.
  • IPG Investment Advisors first reported a position in BioNTech in Q3 2021 and held it in 3 quarters.
  • IPG Investment Advisors's BioNTech position peaked at $707K in Q4 2021.
  • 293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on IPG Investment Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.